PELLERINO, Alessia
PELLERINO, Alessia
[18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas
2024-01-01 GARELLI, Gloria; ROVERA, Guido; LEVIS, Mario; LESCA, Adriana; PELLERINO, Alessia; BRUNO, Francesco; AGOSTI, Alessandra; MANGIA, Maria L.; CIOFFI, Martina; COCCARELLI, Alessandro; MORANA, Giovanni; RICARDI, Umberto; RUDÀ, Roberta; MORBELLI, Silvia; ZOTTA, Michela
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
2021-01-01 Gao Y.; Wei L.; Kim S.J.; Wang L.; He Y.; Zheng Y.; Bertero L.; Pellerino A.; Cassoni P.; Tamagnone L.; Theresa P.K.; Deutsch A.; Zhan H.; Lai J.; Wang Y.; You H.
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study
2023-01-01 Wei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J; Zhan, Huien; Lai, Jing; Kim, Seok Jin; You, Hua
A novel scoring system proposal to guide surgical treatment indications for high grade gliomas in elderly patients: DAK-75
2024-01-01 Bianconi, Andrea; Presta, Roberto; La Cava, Pietro; De Marco, Raffaele; Zeppa, Pietro; Lacroce, Paola; Castaldo, Margherita; Bruno, Francesco; Pellerino, Alessia; Rudà, Roberta; Melcarne, Antonio; Garbossa, Diego; Bo, Mario; Cofano, Fabio
An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression
2009-01-01 Giordana MT; Grifoni S; Piccinini M; Pellerino A; De Marco G ; Buccinnà B ; Lupino E ; Naldi A; Magistrello M; Rinaudo MT
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
2023-01-01 Pellerino, Alessia; Bruno, Francesco; Soffietti, Riccardo; Ruda', Roberta
Antiangiogenic therapy of brain tumors: The role of bevacizumab
2014-01-01 Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma
2024-01-01 Bruno, Francesco; Pellerino, Alessia; Conti Nibali, Marco; Pronello, Edoardo; Cofano, Fabio; Rossi, Marco; Levis, Mario; Bertero, Luca; Soffietti, Riccardo; Cassoni, Paola; Garbossa, Diego; Bello, Lorenzo; Ruda', Roberta
Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes
2012-01-01 Pellerino A; Lomartire A; Naldi A; Buccinna B; Maffeo E; Ramondetti C; Lupino E; Rinaudo MT; Piccinini M; Rainero I; De Marco G; Giordana MT
Blood and cerebrospinal fluid biomarkers in neuro-oncology
2024-01-01 Rudà, Roberta; Pellerino, Alessia; Soffietti, Riccardo
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
2021-01-01 Mo, Francesca; Pellerino, Alessia; Soffietti, Riccardo; Rudà, Roberta
Brain Metastases
2024-01-01 Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Brain metastasis from HER2-positive breast cancer: an evolving landscape
2023-01-01 Soffietti, Riccardo; Pellerino, Alessia
Cancer-Related Cognitive Impairments (CRCIs) in Non-Central Nervous System Adult Patients: Outcome Measures and Methodology of Assessment: A Literature Review
2024-01-01 Pace, Andrea; Tanzilli, Antonio; Marchioni, Enrico; Pellerino, Alessia; Tralongo, Antonino Carmelo; Bini, Paola; Tralongo, Paolo; Cappa, Stefano Francesco
Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults.
2020-01-01 Pellerino A, Bertero L, RudA R, Soffietti R
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
2022-01-01 Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà
Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors
2019-01-01 Pellerino A.; Buffoni L.; Ruda R.; Soffietti R.
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016
2019-01-01 Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo
Current and Future Drugs for Brain Tumors Treatment
2024-01-01 Bruno, Francesco; Pellerino, Alessia; Marchesani, Elena Maria; Rudà, Roberta
Current clinical management of elderly patients with glioma
2020-01-01 Pellerino, Alessia; Bruno, Francesco; Internò, Valeria; Ruda', Roberta; Soffietti, Riccardo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas | 2024 | GARELLI, Gloria; ROVERA, Guido; LEVIS, Mario; LESCA, Adriana; PELLERINO, Alessia; BRUNO, Francesco; AGOSTI, Alessandra; MANGIA, Maria L.; CIOFFI, Martina; COCCARELLI, Alessandro; MORANA, Giovanni; RICARDI, Umberto; RUDÀ, Roberta; MORBELLI, Silvia; ZOTTA, Michela | |
| A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups | 2021 | Gao Y.; Wei L.; Kim S.J.; Wang L.; He Y.; Zheng Y.; Bertero L.; Pellerino A.; Cassoni P.; Tamagnone L.; Theresa P.K.; Deutsch A.; Zhan H.; Lai J.; Wang Y.; You H. | |
| A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study | 2023 | Wei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J; Zhan, Huien; Lai, Jing; Kim, Seok Jin; You, Hua | |
| A novel scoring system proposal to guide surgical treatment indications for high grade gliomas in elderly patients: DAK-75 | 2024 | Bianconi, Andrea; Presta, Roberto; La Cava, Pietro; De Marco, Raffaele; Zeppa, Pietro; Lacroce, Paola; Castaldo, Margherita; Bruno, Francesco; Pellerino, Alessia; Rudà, Roberta; Melcarne, Antonio; Garbossa, Diego; Bo, Mario; Cofano, Fabio | |
| An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression | 2009 | Giordana MT; Grifoni S; Piccinini M; Pellerino A; De Marco G ; Buccinnà B ; Lupino E ; Naldi A; Magistrello M; Rinaudo MT | |
| Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? | 2023 | Pellerino, Alessia; Bruno, Francesco; Soffietti, Riccardo; Ruda', Roberta | |
| Antiangiogenic therapy of brain tumors: The role of bevacizumab | 2014 | Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo | |
| Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma | 2024 | Bruno, Francesco; Pellerino, Alessia; Conti Nibali, Marco; Pronello, Edoardo; Cofano, Fabio; Rossi, Marco; Levis, Mario; Bertero, Luca; Soffietti, Riccardo; Cassoni, Paola; Garbossa, Diego; Bello, Lorenzo; Ruda', Roberta | |
| Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes | 2012 | Pellerino A; Lomartire A; Naldi A; Buccinna B; Maffeo E; Ramondetti C; Lupino E; Rinaudo MT; Piccinini M; Rainero I; De Marco G; Giordana MT | |
| Blood and cerebrospinal fluid biomarkers in neuro-oncology | 2024 | Rudà, Roberta; Pellerino, Alessia; Soffietti, Riccardo | |
| Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance | 2021 | Mo, Francesca; Pellerino, Alessia; Soffietti, Riccardo; Rudà, Roberta | |
| Brain Metastases | 2024 | Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo | |
| Brain metastasis from HER2-positive breast cancer: an evolving landscape | 2023 | Soffietti, Riccardo; Pellerino, Alessia | |
| Cancer-Related Cognitive Impairments (CRCIs) in Non-Central Nervous System Adult Patients: Outcome Measures and Methodology of Assessment: A Literature Review | 2024 | Pace, Andrea; Tanzilli, Antonio; Marchioni, Enrico; Pellerino, Alessia; Tralongo, Antonino Carmelo; Bini, Paola; Tralongo, Paolo; Cappa, Stefano Francesco | |
| Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults. | 2020 | Pellerino A, Bertero L, RudA R, Soffietti R | |
| Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? | 2022 | Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà | |
| Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors | 2019 | Pellerino A.; Buffoni L.; Ruda R.; Soffietti R. | |
| Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 | 2019 | Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo | |
| Current and Future Drugs for Brain Tumors Treatment | 2024 | Bruno, Francesco; Pellerino, Alessia; Marchesani, Elena Maria; Rudà, Roberta | |
| Current clinical management of elderly patients with glioma | 2020 | Pellerino, Alessia; Bruno, Francesco; Internò, Valeria; Ruda', Roberta; Soffietti, Riccardo |